$SCWO
374Water Inc

2024 Q3 Form 10-Q Financial Statement

#000165495424010673 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $36.82K $49.86K
YoY Change -26.16% -95.16%
Cost Of Revenue $43.54K $45.26K
YoY Change -3.79% -94.99%
Gross Profit -$6.722K $4.606K
YoY Change -245.94% -96.4%
Gross Profit Margin -18.26% 9.24%
Selling, General & Admin $2.446M $1.502M
YoY Change 62.87% 63.2%
% of Gross Profit 32603.99%
Research & Development $566.6K $272.0K
YoY Change 108.32% -35.66%
% of Gross Profit 5904.56%
Depreciation & Amortization $9.278K $15.17K
YoY Change -38.84% -9.22%
% of Gross Profit 329.35%
Operating Expenses $3.012M $1.774M
YoY Change 69.84% 32.08%
Operating Profit -$3.019M -$1.769M
YoY Change 70.66% 45.62%
Interest Expense $74.19K $74.97K
YoY Change -1.04% 12190.16%
% of Operating Profit
Other Income/Expense, Net $86.78K $118.5K
YoY Change -26.78% 19234.42%
Pretax Income -$2.932M -$1.651M
YoY Change 77.65% 35.93%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.932M -$1.651M
YoY Change 77.65% 35.93%
Net Earnings / Revenue -7963.72% -3310.22%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.02 -$0.01
COMMON SHARES
Basic Shares Outstanding 132.7M shares 132.7M shares 129.0M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.083M $14.60M
YoY Change -65.18% 44.72%
Cash & Equivalents $5.083M $14.60M
Short-Term Investments $0.00
Other Short-Term Assets $856.6K $206.5K
YoY Change 314.91% -60.88%
Inventory $1.016M $1.804M
Prepaid Expenses $856.6K $206.5K
Receivables $57.44K $17.53K
Other Receivables $24.80K $0.00
Total Short-Term Assets $8.810M $18.34M
YoY Change -51.95% 68.87%
LONG-TERM ASSETS
Property, Plant & Equipment $260.2K $140.0K
YoY Change 85.87% 1945.37%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $15.71K
YoY Change
Total Long-Term Assets $3.405M $1.162M
YoY Change 193.12% 11.95%
TOTAL ASSETS
Total Short-Term Assets $8.810M $18.34M
Total Long-Term Assets $3.405M $1.162M
Total Assets $12.22M $19.50M
YoY Change -37.35% 63.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $892.3K $334.2K
YoY Change 166.97% -51.04%
Accrued Expenses $600.0K
YoY Change
Deferred Revenue $32.77K $183.1K
YoY Change -82.1%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.537M $517.3K
YoY Change 197.08% -63.88%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.537M $517.3K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.537M $517.3K
YoY Change 197.08% -63.88%
SHAREHOLDERS EQUITY
Retained Earnings -$20.91M -$11.14M
YoY Change 87.69% 112.32%
Common Stock $13.29K $13.07K
YoY Change 1.72% 3.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.68M $18.98M
YoY Change
Total Liabilities & Shareholders Equity $12.22M $19.50M
YoY Change -37.35% 63.9%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$2.932M -$1.651M
YoY Change 77.65% 35.93%
Depreciation, Depletion And Amortization $9.278K $15.17K
YoY Change -38.84% -9.22%
Cash From Operating Activities -$2.425M -$1.699M
YoY Change 42.79% 49.04%
INVESTING ACTIVITIES
Capital Expenditures $401.6K $2.920K
YoY Change 13654.45% -187.95%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$401.6K -$2.920K
YoY Change 13654.45% -99.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -25.66K 7.148M
YoY Change -100.36%
NET CHANGE
Cash From Operating Activities -2.425M -1.699M
Cash From Investing Activities -401.6K -2.920K
Cash From Financing Activities -25.66K 7.148M
Net Change In Cash -2.853M 5.446M
YoY Change -152.38% -166.88%
FREE CASH FLOW
Cash From Operating Activities -$2.425M -$1.699M
Capital Expenditures $401.6K $2.920K
Free Cash Flow -$2.827M -$1.701M
YoY Change 66.15% 49.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.50
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
132932335 shares
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
676333 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1511725 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1261995 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
3012378 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1773703 usd
us-gaap Operating Expenses
OperatingExpenses
4911561 usd
us-gaap Operating Expenses
OperatingExpenses
3533602 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3019100 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1769097 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5220303 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3447684 usd
CY2024Q2 us-gaap Interest Income Other
InterestIncomeOther
74192 usd
CY2023Q2 us-gaap Interest Income Other
InterestIncomeOther
74967 usd
us-gaap Interest Income Other
InterestIncomeOther
178812 usd
us-gaap Interest Income Other
InterestIncomeOther
112826 usd
CY2024Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
12588 usd
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
43553 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
84706 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
43938 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
86780 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
118520 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
263518 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
156764 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2932320 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1650577 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4956785 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3290920 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-2932320 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1650577 usd
dei Entity Central Index Key
EntityCentralIndexKey
0000933972
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
132667107 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
132932335 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41420
dei Entity Registrant Name
EntityRegistrantName
374WATER INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-0271109
dei Entity Address Address Line1
EntityAddressAddressLine1
701 W Main Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 410
dei Entity Address City Or Town
EntityAddressCityOrTown
Durham
dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
27701
dei City Area Code
CityAreaCode
440
dei Local Phone Number
LocalPhoneNumber
601-9677
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001
dei Trading Symbol
TradingSymbol
SCWO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
132725652 shares
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5083482 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10445404 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
57437 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
64792 usd
CY2024Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
24801 usd
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
39749 usd
CY2024Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
1771609 usd
CY2023Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
1494553 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
1016231 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2276677 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
856580 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
581085 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
8810140 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
14902260 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
260154 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
230971 usd
CY2024Q2 scwo Equipment In Process Net
EquipmentInProcessNet
2148062 usd
CY2023Q4 scwo Equipment In Process Net
EquipmentInProcessNet
0 usd
CY2024Q2 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
981335 usd
CY2023Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
988029 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
15709 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
0 usd
CY2024Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
3405260 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1219000 usd
CY2024Q2 us-gaap Assets
Assets
12215400 usd
CY2023Q4 us-gaap Assets
Assets
16121260 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
892275 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
572297 usd
CY2024Q2 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
600000 usd
CY2023Q4 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
500000 usd
CY2024Q2 scwo Accrued Legal Settlement
AccruedLegalSettlement
0 usd
CY2023Q4 scwo Accrued Legal Settlement
AccruedLegalSettlement
135000 usd
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
32768 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
130000 usd
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
11743 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
36787 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1536786 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1374084 usd
CY2024Q2 us-gaap Liabilities
Liabilities
1536786 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1374084 usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
132932335 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
132667107 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
13292 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
13266 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31573140 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30684943 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20910289 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15953504 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2471 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2471 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
10678614 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
14747176 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12215400 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16121260 usd
CY2024Q2 us-gaap Revenues
Revenues
36821 usd
CY2023Q2 us-gaap Revenues
Revenues
49863 usd
us-gaap Revenues
Revenues
352099 usd
us-gaap Revenues
Revenues
851321 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
43543 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
45257 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
660841 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
765403 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
-6722 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
4606 usd
us-gaap Gross Profit
GrossProfit
-308742 usd
us-gaap Gross Profit
GrossProfit
85918 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
566568 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
271964 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1101715 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
627869 usd
CY2024Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
777825 usd
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
733121 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1429429 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1451881 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
615987 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
92285 usd
us-gaap Professional Fees
ProfessionalFees
868692 usd
us-gaap Professional Fees
ProfessionalFees
191857 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1051998 usd
us-gaap Net Income Loss
NetIncomeLoss
-4956785 usd
us-gaap Net Income Loss
NetIncomeLoss
-3290920 usd
CY2024Q2 scwo Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.02
CY2023Q2 scwo Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.01
scwo Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.04
scwo Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.03
CY2024Q2 scwo Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
132801137 shares
CY2023Q2 scwo Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
129389098 shares
scwo Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
132735552 shares
scwo Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
128274091 shares
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-2932320 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-1650577 usd
us-gaap Profit Loss
ProfitLoss
-4956785 usd
us-gaap Profit Loss
ProfitLoss
-3290920 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4943 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5438 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2932320 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1645634 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4956785 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3285482 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
14747176 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4500 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
183200 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2024465 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
12910411 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
338100 usd
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
275384 usd
CY2024Q2 scwo Stock Options Issued For Legal Settlement
StockOptionsIssuedForLegalSettlement
112697 usd
CY2024Q2 scwo Issuance Of Shares Of Common Stock For Cash Net Of Issuance Costs Amount
IssuanceOfSharesOfCommonStockForCashNetOfIssuanceCostsAmount
-25658 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-2932320 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
10678614 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8253612 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8294708 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
214924 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
824 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
18967 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1640343 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
15142692 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5146730 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
71200 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
18 usd
CY2023Q2 scwo Exercised Of Warrants Amount
ExercisedOfWarrantsAmount
37500 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
228812 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
4943 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1650577 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
18981318 usd
us-gaap Profit Loss
ProfitLoss
-4956785 usd
us-gaap Profit Loss
ProfitLoss
-3290920 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
50953 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
44281 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
342600 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
scwo Stock Based Compensation Expense
StockBasedCompensationExpense
458584 usd
scwo Stock Based Compensation Expense
StockBasedCompensationExpense
514934 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5767 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
22303 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Inventory Lifo Reserve Effect On Income Net
InventoryLIFOReserveEffectOnIncomeNet
50000 usd
us-gaap Inventory Lifo Reserve Effect On Income Net
InventoryLIFOReserveEffectOnIncomeNet
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7355 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17526 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-14948 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
0 usd
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
277056 usd
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
790863 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
608838 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
143785 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
275495 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
52998 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
15709 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
0 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
319978 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1115353 usd
scwo Increase Decrease In Accrued Contract Loss Provision
IncreaseDecreaseInAccruedContractLossProvision
100000 usd
scwo Increase Decrease In Accrued Contract Loss Provision
IncreaseDecreaseInAccruedContractLossProvision
0 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-97232 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-17048 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-25044 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-13528 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4934044 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4877039 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
46093 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7303 usd
scwo Payments To Acquire Of Equipment In Process
PaymentsToAcquireOfEquipmentInProcess
328778 usd
scwo Payments To Acquire Of Equipment In Process
PaymentsToAcquireOfEquipmentInProcess
0 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
27349 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
5623 usd
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
0 usd
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
1963430 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-402220 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1950504 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-25658 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13478959 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-25658 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13478959 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5361922 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
10552424 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10445404 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4046937 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5083482 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14599361 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Stock Issued1
StockIssued1
1819284 usd
us-gaap Stock Issued1
StockIssued1
0 usd
CY2024Q2 us-gaap Cash
Cash
5083482 usd
CY2023Q4 us-gaap Cash
Cash
10445404 usd
us-gaap Inventory Recall Expense
InventoryRecallExpense
50000 usd
CY2023 us-gaap Inventory Recall Expense
InventoryRecallExpense
0 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
297839 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
251747 usd
CY2024Q2 us-gaap Real Estate Accumulated Depreciation
RealEstateAccumulatedDepreciation
37685 usd
CY2023Q4 us-gaap Real Estate Accumulated Depreciation
RealEstateAccumulatedDepreciation
20776 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
260154 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
230971 usd
CY2024Q2 us-gaap Depreciation
Depreciation
9278 usd
CY2023Q2 us-gaap Depreciation
Depreciation
892 usd
us-gaap Depreciation
Depreciation
16910 usd
us-gaap Depreciation
Depreciation
10417 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents and customer concentrations. Deposits with financial institutions are insured, up to certain limits, by the Federal Deposit Insurance Corporation (“FDIC”). The Company’s cash deposits often exceed the FDIC insurance limit; however, all deposits are maintained with high credit quality institutions and the Company has not experienced any losses in such accounts. The financial condition of financial institutions is periodically reassessed, and the Company believes the risk of any loss is minimal. The Company believes the risk of any loss on cash due to credit risk is minimal. Furthermore, the Company performs ongoing credit evaluations of its customers and generally does not require collateral.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Significant customers and suppliers are those that account for greater than 10% of the Company’s revenues and purchases. One customer made up approximately 87% and over 90% of revenue for the six month periods ended June 30, 2024 and 2023, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the six months ended June 30, 2024 and 2023, the Company purchased a substantial portion of fabrication and manufacturing services from one related party vendor, Merrell Bros Fabrication, LLC (“Merrell Bros.”) (see Note 8).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Refer to Note 9 for a license agreement we have with Duke University for the SCWO technology used in our systems.</p>
CY2024Q2 scwo Revenues From Sales
RevenuesFromSales
9773 usd
CY2024Q2 scwo Revenues From Sale Of Treatability Services
RevenuesFromSaleOfTreatabilityServices
27048 usd
CY2023Q2 scwo Revenues From Sales
RevenuesFromSales
49863 usd
CY2023Q2 scwo Revenues From Sale Of Treatability Services
RevenuesFromSaleOfTreatabilityServices
0 usd
scwo Revenues From Sales
RevenuesFromSales
305869 usd
scwo Revenues From Sale Of Treatability Services
RevenuesFromSaleOfTreatabilityServices
46230 usd
scwo Revenues From Sales
RevenuesFromSales
843321 usd
scwo Revenues From Sale Of Treatability Services
RevenuesFromSaleOfTreatabilityServices
8000 usd
us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
600000 usd
CY2023 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
500000 usd
scwo Share Based Description
ShareBasedDescription
cumulative adjustment of approximately $55,000 in the quarter ended December 31, 2023 to reduce its forfeiture rate estimate to approximately 5% of the total stock-based compensation recognized during the year
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1101715 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
627869 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
566568 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
271964 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, reserve for obsolete inventory, accrued contract loss provisions, total estimated costs to be incurred on long-term contracts, and valuation allowance against deferred tax assets.</p>
CY2024Q2 us-gaap Capital
Capital
7273354 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20910289 usd
us-gaap Net Income Loss
NetIncomeLoss
-4956785 usd
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
4934044 usd
us-gaap Proceeds From Other Operating Activities
ProceedsFromOtherOperatingActivities
0 usd
CY2023 us-gaap Proceeds From Other Operating Activities
ProceedsFromOtherOperatingActivities
13400000 usd
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
1066231 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
457393 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
0 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1819284 usd
CY2024Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
50000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
1016231 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2276677 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
988029 usd
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
27349 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
34043 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
981335 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17115 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16954 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
34043 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
33864 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
34629 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
69257 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
69257 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
69257 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
69257 usd
CY2024Q2 scwo Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
669678 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
981335 usd
CY2023Q2 us-gaap Revenues
Revenues
49863 usd
scwo Premiums Revenue Percentage
PremiumsRevenuePercentage
1 pure
CY2024Q2 us-gaap Revenues
Revenues
36821 usd
scwo Premiums Revenue Percentage
PremiumsRevenuePercentage
1 pure
us-gaap Revenues
Revenues
352099 usd
CY2024Q2 scwo Premiums Revenue Percentage
PremiumsRevenuePercentage
1 pure
us-gaap Revenues
Revenues
851321 usd
CY2023Q2 scwo Premiums Revenue Percentage
PremiumsRevenuePercentage
1 pure
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
130000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
200109 usd
scwo Billings Deferred Unearned Revenue
BillingsDeferredUnearnedRevenue
2768 usd
CY2023 scwo Billings Deferred Unearned Revenue
BillingsDeferredUnearnedRevenue
58000 usd
scwo Refundable Deposit Returned
RefundableDepositReturned
-100000 usd
CY2023 scwo Refundable Deposit Returned
RefundableDepositReturned
0 usd
us-gaap Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
0 usd
CY2023 us-gaap Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
128109 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
32768 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
130000 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1494553 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
918164 usd
scwo Services Performed But Unbilled
ServicesPerformedButUnbilled
296056 usd
CY2023 scwo Services Performed But Unbilled
ServicesPerformedButUnbilled
1061612 usd
scwo Services Billed
ServicesBilled
-19040 usd
CY2023 scwo Services Billed
ServicesBilled
-485223 usd
CY2024Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
1771609 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1494553 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 scwo Preferred Stock Shares Designated
PreferredStockSharesDesignated
1000000 shares
scwo Options Granted
OptionsGranted
6700000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2962000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.26
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2962000 shares
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.26
scwo Stock In Excess Percentage Of Outstanding Share
StockInExcessPercentageOfOutstandingShare
0.05 pure
scwo Related Party Transaction Expenses From Transactions With Related Parties
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParties
272031 usd
scwo Related Party Cost
RelatedPartyCost
68691 usd
CY2024Q3 scwo Monthly Rent Payment
MonthlyRentPayment
4725 usd
scwo Non Rule Tenb Fifty One Arr Adopted Flag
NonRuleTenbFiftyOneArrAdoptedFlag
none
scwo Rule Tenb Fifty One Arr Adopted Flag
RuleTenbFiftyOneArrAdoptedFlag
adoption
scwo Rule Tenb Fifty One Arr Trmntd Flag
RuleTenbFiftyOneArrTrmntdFlag
termination
scwo Non Rule Tenb Fifty One Arr Trmntd Flag
NonRuleTenbFiftyOneArrTrmntdFlag
non-Rule 10b5-1

Files In Submission

Name View Source Status
0001654954-24-010673-index-headers.html Edgar Link pending
0001654954-24-010673-index.html Edgar Link pending
0001654954-24-010673.txt Edgar Link pending
0001654954-24-010673-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
scwo-20240630.xsd Edgar Link pending
scwo_10q.htm Edgar Link pending
scwo_ex102.htm Edgar Link pending
scwo_ex311.htm Edgar Link pending
scwo_ex312.htm Edgar Link pending
scwo_ex321.htm Edgar Link pending
scwo_ex322.htm Edgar Link pending
Show.js Edgar Link pending
scwo-20240630_cal.xml Edgar Link unprocessable
scwo-20240630_def.xml Edgar Link unprocessable
scwo-20240630_lab.xml Edgar Link unprocessable
scwo-20240630_pre.xml Edgar Link unprocessable
scwo_10q_htm.xml Edgar Link completed